Citadel Advisors’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6809 |
|
|
2023
Q1 | – | Sell |
-2,575
| Closed | -$11.7K | – | 6910 |
|
|
2022
Q4 | $11.7K | Buy |
+2,575
| New | +$11.7K | ﹤0.01% | 5666 |
|
|
2022
Q3 | – | Sell |
-3,603
| Closed | -$39K | – | 7049 |
|
|
2022
Q2 | $39K | Buy |
+3,603
| New | +$39K | ﹤0.01% | 5572 |
|
|
2022
Q1 | – | Sell |
-838
| Closed | -$30K | – | 7468 |
|
|
2021
Q4 | $30K | Buy |
+838
| New | +$30K | ﹤0.01% | 6269 |
|
|
2021
Q3 | – | Sell |
-1,111
| Closed | -$155K | – | 7360 |
|
|
2021
Q2 | $155K | Buy |
1,111
+407
| +58% | +$56.8K | ﹤0.01% | 5738 |
|
|
2021
Q1 | $204K | Buy |
+704
| New | +$204K | ﹤0.01% | 5393 |
|